Literature DB >> 10644367

A role for SKIP in EBNA2 activation of CBF1-repressed promoters.

S Zhou1, M Fujimuro, J J Hsieh, L Chen, S D Hayward.   

Abstract

EBNA2 is essential for Epstein-Barr virus (EBV) immortalization of B lymphocytes. EBNA2 functions as a transcriptional activator and targets responsive promoters through interaction with the cellular DNA binding protein CBF1. We have examined the mechanism whereby EBNA2 overcomes CBF1-mediated transcriptional repression. A yeast two-hybrid screen performed using CBF1 as the bait identified a protein, SKIP, which had not previously been recognized as a CBF1-associated protein. Protein-protein interaction assays demonstrated contacts between SKIP and the SMRT, CIR, Sin3A, and HDAC2 proteins of the CBF1 corepressor complex. Interestingly, EBNA2 also interacted with SKIP in glutathione S-transferase affinity and mammalian two-hybrid assays and colocalized with SKIP in immunofluorescence assays. Interaction with SKIP was not affected by mutation of EBNA2 conserved region 6, the CBF1 interaction region, but was abolished by mutation of conserved region 5. Mutation of conserved region 5 also severely impaired EBNA2 activation of a reporter containing CBF1 binding sites. Thus, interaction with both CBF1 and SKIP is necessary for efficient promoter activation by EBNA2. A model is presented in which EBNA2 competes with the SMRT-corepressor complex for contacts on SKIP and CBF1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644367      PMCID: PMC111672          DOI: 10.1128/jvi.74.4.1939-1947.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family.

Authors:  W M Yang; Y L Yao; J M Sun; J R Davie; E Seto
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

2.  The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.

Authors:  S R Grossman; E Johannsen; X Tong; R Yalamanchili; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

3.  The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.

Authors:  X Tong; F Wang; C J Thut; E Kieff
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

4.  EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.

Authors:  P D Ling; J J Hsieh; I K Ruf; D R Rawlins; S D Hayward
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk.

Authors:  P D Ling; S D Hayward
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

6.  Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.

Authors:  E Johannsen; E Koh; G Mosialos; X Tong; E Kieff; S R Grossman
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

7.  The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.

Authors:  L Waltzer; F Logeat; C Brou; A Israel; A Sergeant; E Manet
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

8.  EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

Authors:  A J Sinclair; I Palmero; G Peters; P J Farrell
Journal:  EMBO J       Date:  1994-07-15       Impact factor: 11.598

9.  B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2.

Authors:  B Kempkes; D Spitkovsky; P Jansen-Dürr; J W Ellwart; E Kremmer; H J Delecluse; C Rottenberger; G W Bornkamm; W Hammerschmidt
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

10.  The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.

Authors:  G Laux; B Adam; L J Strobl; F Moreau-Gachelin
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

View more
  50 in total

1.  SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function.

Authors:  S Zhou; M Fujimuro; J J Hsieh; L Chen; A Miyamoto; G Weinmaster; S D Hayward
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex.

Authors:  S Zhou; S D Hayward
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

4.  Ski interacts with the evolutionarily conserved SNW domain of Skip.

Authors:  T Prathapam; C Kühne; M Hayman; L Banks
Journal:  Nucleic Acids Res       Date:  2001-09-01       Impact factor: 16.971

5.  SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway.

Authors:  Franz Oswald; Ulrike Kostezka; Kathy Astrahantseff; Soizic Bourteele; Karin Dillinger; Ulrich Zechner; Leopold Ludwig; Monika Wilda; Horst Hameister; Walter Knöchel; Susanne Liptay; Roland M Schmid
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

6.  Skip interacts with the retinoblastoma tumor suppressor and inhibits its transcriptional repression activity.

Authors:  Tulasiram Prathapam; Christian Kühne; Lawrence Banks
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

7.  Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.

Authors:  R Peng; J Tan; P D Ling
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.

Authors:  Daniel Portal; Bo Zhao; Michael A Calderwood; Thomas Sommermann; Eric Johannsen; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

9.  Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis.

Authors:  Jae Myun Lee; Kyoung-Ho Lee; Magdalena Weidner; Barbara A Osborne; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-23       Impact factor: 11.205

10.  CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation.

Authors:  Bogaslaw Kwiatkowski; Szu Yu Jenny Chen; William H Schubach
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.